Cataract surgery. Unspecified disorder of vitreous body
Conditions
Interventions
Intervention 1: Intervention group: In dexmedetomidine group (D), patients will receive 1 /g / kg of dexmedetomidine in 20 ml of normal saline for 10 minutes followed by infusion of dexmedetomidine at
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Patients aged 35 to 85 years Patients who are candidates for phycoemolysis cataract surgery Patients undergoing local anesthesia and sedation in this surgery have Class 1 and 2 of the American Anesthesia Association Patients with controlled blood pressure
Exclusion criteria
Exclusion criteria: History of any allergy to the drug used in the design History of drug addiction, alcohol, benzodiazepine Pregnancy Congestive heart failure History of head trauma Glaucoma Hypotension Evidence of increased intracranial pressure Psychosis Schizophrenia Active upper respiratory tract infection Asthma Chronic respiratory disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation level based on ramsay score. Timepoint: Every 5 minutes during surgery. Method of measurement: Ramsay score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial pressure. Timepoint: Before intervention, every 5 minutes after the intervention and every 10 minutes after the end of the intervention for 30 minutes. Method of measurement: Pressure gauge.;Oxygen saturation. Timepoint: Before intervention, every 5 minutes after the intervention and every 10 minutes after the end of the intervention for 30 minutes. Method of measurement: Pulse oximeter.;Heart rate. Timepoint: Before intervention, every 5 minutes after the intervention and every 10 minutes after the end of the intervention for 30 minutes. Method of measurement: Pulse oximeter.;Intensity of pain. Timepoint: Before intervention, every 5 minutes after the intervention and every 10 minutes after the end of the intervention for 30 minutes. Method of measurement: Universal Pain assessment tool.;Recovery time. Timepoint: After completing the intervention until the withdrawal from the recovery. Method of measurement: Minute Numbers. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidreza Shetabi
Esfahan University of Medical Sciences
Outcome results
None listed